安捷伦科技（NYSE:A）副总裁出售价值464,970美元的股票 - MarketBeat报道
Agilent Technologies (NYSE:A) VP Sells $464,970.00 in Stock - MarketBeat
生命科学资讯
生物技术与制药领域的最新动态
赛默飞世尔科技扩大亚洲生物工艺能力 - Investing.com
Thermo Fisher expands bioprocessing capabilities across Asia - Investing.com
Thermo Fisher (TMO) 通过新建及扩建设计中心增强亚洲生物制药支持 - Stock Titan
Thermo Fisher (TMO) boosts Asia biopharma support with new and expanded design centers - Stock Titan
Genetic testing transformed her cancer care—and her family tree - Illumina
Hospitals challenge 340B rebate pilot program in Maine federal court
Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key P - PharmiWeb.com
Pentagon seeks to add WuXi AppTec to military list: report
New York judge revives Bristol Myers dispute over Celgene deal
Janux T细胞接合器数据导致股价下跌，但分析师仍看好其成为同类最佳潜力。
Janux T-cell engager data sink stock, but analysts still see best-in-class potential
FDA发布草案指导以减少特定抗体试验中的灵长类动物使用。
FDA issues draft guidance to reduce primate testing for certain antibodies
波士顿科学宣布其Farapoint局灶脉冲场消融导管获欧洲批准。
Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter
CDER主任理查德·帕兹杜尔在任命后不久即将退休
CDER head Richard Pazdur set to retire shortly after appointment
FDA将取消单克隆抗体开发中的部分猴子试验。
FDA to remove some monkey testing from monoclonal antibody development
FDA药品监管负责人理查德·帕兹杜尔即将退休。
Richard Pazdur, FDA drug czar, to retire from agency
2025年12月2日赛默飞世尔科技(TMO)股价动态：价格走势、汇丰银行上调评级、新债务协议及2026-2030年预测 - ts2.tech
Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts - ts2.tech
科技成为数字疗法新前沿
Tech emerges as a new frontier for digital therapeutics
FDA详述计划：部分抗体药物将减少动物试验。
FDA details plan to scale back animal tests for some antibody drugs